Cannabinoids and dystonia: an issue yet to be defined
Marcello Mario Mascia1, Daniele Carmagnini2, Giovanni Defazio2
1Department of Medical Sciences and Public Health, Neurology Unit, University of Cagliari and AOU Cagliari, Monserrato, Cagliari, Italy. marcello.mas@tiscali.it.
Cannabinoids show promise as a complementary treatment for dystonia, a movement disorder. While single cases suggest effectiveness, further research is needed to confirm their role in managing dystonia symptoms.
Area of Science:
- Neurology
- Movement Disorders
- Pharmacology
Background:
- Dystonia is a complex movement disorder with both motor and non-motor symptoms.
- Current treatments like botulinum toxin and deep brain stimulation have limitations.
- Cannabinoids are explored for neurological disorders, but their role in dystonia is unclear.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Opioid Receptors: Overview
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists


